These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 36255514)

  • 1. Letter to the Editor Concerning "An Evidence-Based Staging System for Mucosal Melanoma: A Proposal," by Smith, Henry et al.
    Guo J; Balch CM
    Ann Surg Oncol; 2022 Dec; 29(Suppl 3):626-627. PubMed ID: 36255514
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter to the Editor Regarding "An Evidence-Based Staging System for Mucosal Melanoma: A Proposal".
    Smith HG; Harrington KJ; Smith MJF
    Ann Surg Oncol; 2022 Dec; 29(Suppl 3):625. PubMed ID: 36175709
    [No Abstract]   [Full Text] [Related]  

  • 3. Letter to the Editor concerning: Kolosov et al: Primary melanoma of the anorectal region: Clinical and histopathological review of 17 cases. A retrospective cohort study. Colorect Dis 2021: DOI: 10.1111/codi.15816.
    Kahlke V; Laubert T; Schneider J; Jongen J
    Colorectal Dis; 2021 Nov; 23(11):3028. PubMed ID: 34529894
    [No Abstract]   [Full Text] [Related]  

  • 4. Comments to the Letter to the Editor of S. Shahsavari et al. concerning "Predicting medical complications in spine surgery: evaluation of a novel online risk calculator" by M. F. Kasparek et al. (Eur Spine J: doi:10.1007/s00586-018-5707-9) and the reply to the Letter to the Editor of S. Shahsavari et al. concerning "Predicting medical complications in spine surgery: evaluation of a novel online risk calculator" by M. F. Kasparek et al. (Eur Spine J: doi:10.1007/s00586-018-5707-9).
    Edwards KL
    Eur Spine J; 2018 Nov; 27(11):2889-2890. PubMed ID: 30327911
    [No Abstract]   [Full Text] [Related]  

  • 5. Letter to the editor regarding the paper by Loquai C et al. 'Use of complementary and alternative medicine: a multicenter cross-sectional study in 1089 melanoma patients'.
    Fabre E; Thomas-Schoemann A; Blanchet B
    Eur J Cancer; 2017 Nov; 85():158-159. PubMed ID: 28877854
    [No Abstract]   [Full Text] [Related]  

  • 6. Reply to the letter to the editor 'What type of man against machine?' by H. Smith.
    Haenssle HA; Fink C
    Ann Oncol; 2018 Sep; 29(9):2024-2025. PubMed ID: 29992324
    [No Abstract]   [Full Text] [Related]  

  • 7. Reply to the article "The AJCC staging proposal for cutaneous melanoma: comments by the EORTC Melanoma Group", by D. J. Ruiter et al. (Ann Oncol 2001; 12: 9-11). American Joint Committee on Cancer.
    Balch CM; Mihm MC
    Ann Oncol; 2002 Jan; 13(1):175-6. PubMed ID: 11863103
    [No Abstract]   [Full Text] [Related]  

  • 8. Letter to the Editor: CONVERGENCES AND DIVERGENCES IN THE ICD-11 VS. DSM-5 CLASSIFICATION OF MOOD DISORDERS.
    Cerbo AD
    Turk Psikiyatri Derg; 2021; 32(4):293-295. PubMed ID: 34964106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Letter to the Editor concerning "Proposal for a new trajectory for subaxial cervical lateral mass screws" by S. Amhaz-Escanlar et al. (Eur Spine J; 2018: doi:10.1007/s00586-018-5670-5).
    Camino Willhuber G
    Eur Spine J; 2018 Oct; 27(10):2660. PubMed ID: 30078054
    [No Abstract]   [Full Text] [Related]  

  • 10. ASO Author Reflections: Staging System for Mucosal Melanoma: A Proposal to Fill a Gap.
    Cui C; Lian B; Guo J
    Ann Surg Oncol; 2022 Aug; 29(8):5235-5236. PubMed ID: 35412206
    [No Abstract]   [Full Text] [Related]  

  • 11. Reply to the letter to the editor 'Man against machine: diagnostic performance of a deep learning convolutional neural network for dermoscopic melanoma recognition in comparison to 58 dermatologists' by H. A. Haenssle et al.
    Haenssle HA; Fink C; Rosenberger A; Uhlmann L
    Ann Oncol; 2019 May; 30(5):854-857. PubMed ID: 30689691
    [No Abstract]   [Full Text] [Related]  

  • 12. Answer to the Letter to the Editor of V. Kumar et al. concerning "Can standard anterior Smith-Robinson supramanubrial approach be utilized for approach down to T2 or T3?" by Singhatanadgige W, Zebala LP, Luksanapruksa P, Riew KD [Eur Spine J (2017) 26:2357-2362].
    Singhatanadgige W; Zebala LP; Luksanapruksa P; Riew KD
    Eur Spine J; 2019 Dec; 28(12):3095-3096. PubMed ID: 31578636
    [No Abstract]   [Full Text] [Related]  

  • 13. Answer to the Letter to the Editor of G.C. Willhuber concerning "Proposal for a new trajectory for subaxial cervical lateral mass screws" by S. Amhaz-Escanlar et al. (Eur Spine J; 2018: doi: 10.1007/s00586-018-5670-5).
    Díez-Ulloa MA
    Eur Spine J; 2018 Oct; 27(10):2661-2662. PubMed ID: 30128760
    [No Abstract]   [Full Text] [Related]  

  • 14. An Evidence-Based Staging System for Mucosal Melanoma: A Proposal.
    Cui C; Lian B; Zhang X; Wu D; Li K; Si L; Yang Y; Tian H; Zhou L; Chi Z; Sheng X; Kong Y; Mao L; Wang X; Bai X; Yan X; Li S; Dai J; Tang B; Wei X; Gershenwald JE; Balch CM; Guo J
    Ann Surg Oncol; 2022 Aug; 29(8):5221-5234. PubMed ID: 35397739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Letter to the Editor re: Dreher, H.M., Smith Glasgow, M.E., and Schreiber, J. entitled "The use of 'high stakes testing' in nursing education: Rhetoric or rigor?" (July 2019) and Spurlock, D.R., and Phelan, J.'s letter to the editor, entitled "Accuracy and completeness are required: A response to Dreher et al" (October 2019).
    Morrison S; Nibert A
    Nurs Forum; 2020 Jul; 55(3):537-538. PubMed ID: 32222970
    [No Abstract]   [Full Text] [Related]  

  • 16. Reply to the letter to the editor 'Plasma vemurafenib concentrations in advanced BRAFV600mut melanoma patients: impact on tumor response and tolerance' by Funck-Brentano et al.
    Funck-Brentano E; Alvarez JC; Longvert C; Abe E; Beauchet A; Saiag P; Funck-Brentano C
    Ann Oncol; 2016 Feb; 27(2):364-5. PubMed ID: 26578725
    [No Abstract]   [Full Text] [Related]  

  • 17. On representative and illustrative comparisons with real data in bioinformatics: response to the letter to the editor by Smith et al.
    Boulesteix AL
    Bioinformatics; 2013 Oct; 29(20):2664-6. PubMed ID: 23929033
    [No Abstract]   [Full Text] [Related]  

  • 18. Letter to the Editor for Lutz Kretschmer et al., J Dtsch Dermatol Ges, 2011; 2: 123–128.
    Morcos B
    J Dtsch Dermatol Ges; 2011 May; 9(5):430; author reply 431. PubMed ID: 21489154
    [No Abstract]   [Full Text] [Related]  

  • 19. Response to the Waalkes et al., Letter to the editor concerning our "letter to the editor, Re: Lung tumors in mice induced by "whole-life" inorganic arsenic exposure at human relevant doses, Waalkes et al., Arch Toxicol, 2014".
    Cohen SM; Arnold LL; Klaunig JE; Goodman JI
    Arch Toxicol; 2015 Nov; 89(11):2167-8. PubMed ID: 26449479
    [No Abstract]   [Full Text] [Related]  

  • 20. Increased sampling will lead to an increase in detection, but is it clinically relevant? Reply letter regarding: "Treatment influencing down-staging in EORTC Melanoma Group sentinel node histological protocol compared with complete step-sectioning: a national multicentre study" by Riber-Hansen et al.
    van Akkooi AC; Cook MG; Eggermont AM
    Eur J Cancer; 2012 Oct; 48(15):2488-9; author reply 2486-7. PubMed ID: 22698385
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.